HOME >> MEDICINE >> NEWS
Generic vs. name brand medications

s introduce more new (and often more effective) drugs, which enjoy patent protection before they have to face competition from generics.

--The science demonstrating that generics are, in fact, bioequivalent to the name brands with which they compete has improved greatly. One argument opposing generics has traditionally been that they are not a true substitute, but now it is easier to tell if that is true scientifically, Kirking said.

--Significant restructuring in the pharmaceutical industry has led to cases where the same company makes a brand-name drug and its generic equivalent, or owns a subsidiary that does, while those companies that make only generics are merging and consolidating.

Kirking, who is professor and chair of the Department of Social and Administrative Sciences in U-M's College of Pharmacy and a research scientist in health management and policy at the U-M School of Public Health, said many people in the health care industries looked to generics as a quick-fix way to cut costs. For a number of reasons, that is not realistic, he said.

For example, a number of the most expensive medications are still under patent so no generics exist, and once the end of the patent draws near, clever pharmaceutical manufacturers reformulate---such as providing a 12-hour pill instead of one that works for four hours---and get a patent on the new and improved drug.

Kirking said therapeutic interchange might prove to play a bigger role in balancing the desire to reduce costs with the need to provide effective medication. Therapeutic interchange involves moving a patient from one drug to a different but related drug, as opposed to its chemical twin generic. This can be helpful both because very similar drugs sometimes have very different prices, as well as because one drug might not have a generic equivalent, but a related drug might. That could lead to first moving the patient from one brand-name medication to another, then t
'"/>

Contact: Colleen Newvine
cnewvine@umich.edu
734-647-4411
University of Michigan
10-Oct-2001


Page: 1 2 3

Related medicine news :

1. Generic drug use varies widely by state, study reveals
2. Generic anti-inflammatory causes significantly fewer GI complications than branded medications
3. Generics slow rising cost of prescription drugs in 2003
4. First quarter prescription drug spending: Generic drugs slow upward trend
5. Study shows patch therapy may be as effective as oral medications
6. Use of potentially inappropriate medications among elderly common in some European countries
7. Low-dose aspirin and stomach ulcer medications better for heart patients with GI complications
8. Heart patients treated by non-cardiologists less likely to receive medications
9. Conference to examine effects of dietary supplements in patients taking blood thinning medications
10. Doctors must consider potentially inappropriate medications when treating elderly
11. Adults taking eplileptic medications more likely to be unemployed

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... , ... Grass pollen is the main cause of hay fever in the United States, with ... pollen runs from May to July each year; with the worst time for sufferers being ... barrier balms ( http://www.haymax.us ) provide an effective defense against grass pollen; they are proven ...
(Date:3/29/2017)... ... , ... Sports Brand EXOUS Bodygear announced today a special sale price for ... remaining days of March, the price will be only $19.97. The EXOUS Bodygear 65cm ... $10 (regular retail price $19.97). , The special promotional prices are to help individuals ...
(Date:3/29/2017)... ... March 29, 2017 , ... Based on research ... challenges employers face in trying to balance both short-term and long-term benefits demands. ... Adding to the growing complexity, companies are finding that the short-term strategies used ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... (MOBs) and other outpatient facilities, and who are the most active developers? ... questions, Revista and Healthcare Real Estate Insights (HREI) found that outpatient medical real ...
(Date:3/29/2017)... ... March 29, 2017 , ... HealthCareMandA.com will host an important webinar — Home ... PM ET. A recording of the webinar will also be made available following its ... and hospice companies are still popular targets for healthcare investors. This highly fragmented sector ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017  Bodycad announced today that it ... 510(k) clearance for its Bodycad Unicompartmental Knee System, ... orthopaedic restoration. Bodycad is the first Canadian company ... implant system. Bodycad,s revolutionary Unicompartmental ... of the patient,s unique anatomical features and kinematics. ...
(Date:3/29/2017)... Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer ... N. Stengone , president and chief executive officer, will present an ... Annual Healthcare Conference on Wednesday, April 5, 2017, at 11:20 ... in New York City . About ... Avelas ...
(Date:3/29/2017)... Research and Markets has announced the addition of the ... to their offering. ... The global orthopedic navigation system market is ... population prone to orthopedic diseases is a key contributing factor ... period. Osteoarthritis and osteoporosis are most common disorders in the ...
Breaking Medicine Technology:
Cached News: